Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.76 USD | -0.50% | -4.44% | +32.60% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.60% | 2.06B | |
-1.78% | 41.36B | |
+45.09% | 41.3B | |
+4.01% | 39.61B | |
-15.14% | 25.62B | |
+3.16% | 24.09B | |
-24.08% | 18.38B | |
-2.67% | 11.82B | |
+24.76% | 11.85B | |
+7.01% | 11.07B |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- Kymera Therapeutics Says KT-333 to Treat Cutaneous T-Cell Lymphoma Secures Orphan Drug Designation